FN1 and diabetes mellitus: However, they demonstrated that intravenous injection of miR-146a mimics in type 1 and 2 diabetic rats may reinstate retinal miR-146a expression and reduce fibronectin rate in diabetes but not kidneys, and additional investigations are needed to establish this therapeutic method in diabetic nephropathy [58, 78].